Evaluation of the Behavioral and Psychological Symptoms in Patients with Vitiligo in China

References

• Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74–84. doi:10.1016/S0140-6736(14)60763-7
   PubMed Web of Science ®Google Scholar
• Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clin Exp Dermatol. 2010;35(7):736–739. doi:10.1111/j.1365-2230.2009.03765.x
   PubMed Web of Science ®Google Scholar
• Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206–1212. doi:10.1111/j.1365-4632.2011.05377.x
   PubMed Web of Science ®Google Scholar
• Morrison B, Burden-Teh E, Batchelor JM, Mead E, Grindlay D, Ratib S. Quality of life in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2017;177(6):e338–e339. doi:10.1111/bjd.15933
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Sheth V, Rodrigues M, et al. Vitiligo is not a cosmetic disease. J Am Acad Dermatol. 2015;73(5):883–885. doi:10.1016/j.jaad.2015.07.039
   PubMed Web of Science ®Google Scholar
• Picardi A, Pasquini P, Cattaruzza MS, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom. 2003;72(3):150–158. doi:10.1159/000069731
   PubMed Web of Science ®Google Scholar
• Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177(3):708–718. doi:10.1111/bjd.15199
   PubMed Web of Science ®Google Scholar
• Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178(4):863–878. doi:10.1111/bjd.16049
   PubMed Web of Science ®Google Scholar
• Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(8):1343–1351. doi:10.1111/jdv.14739
   PubMed Web of Science ®Google Scholar
• Bidaki R, Majidi N, Moghadam Ahmadi A, et al. Vitiligo and social acceptance. Clin Cosmet Investig Dermatol. 2018;11:383–386. doi:10.2147/CCID.S151114
   PubMed Web of Science ®Google Scholar
• Taïeb A, Meurant JM. Should we prioritize psychological interventions in the management of vitiligo? J Eur Acad Dermatol Venereol. 2018;32(12):2053–2054. doi:10.1111/jdv.15297
   PubMed Web of Science ®Google Scholar
• Patel KR, Singam V, Vakharia PP, et al. Measurement properties of three assessments of burden used in atopic dermatitis in adults. Br J Dermatol. 2019;180(5):1083–1089. doi:10.1111/bjd.17243
   PubMed Web of Science ®Google Scholar
• Liu YY, Wu SJ, Li YQ, Shao F, Su JK, Liu XF. A survey of mental symptoms of Chinese population based on SCL-90. Chin Ment Health J. 2018;32(5):437–441.
   Google Scholar
• Wang XD, Wang XL, Ma H. Manual of mental health assessment scale. Beijing. 1999;13:213–214.
   Google Scholar
• Shen XH, Jiang QJ. Report on application of Chinese version of MCMQ in 701 patients. Chin J Behav Med Sci. 2000;9(1):18–20.
   Google Scholar
• Gupta V, Sreenivas V, Mehta M, et al. What do vitiligo impact scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach. Br J Dermatol. 2019;180(3):580–585. doi:10.1111/bjd.17040
   PubMed Web of Science ®Google Scholar
• Amer AAA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608–614. doi:10.1111/ijd.13198
   PubMed Web of Science ®Google Scholar
• Bonotis K, Pantelis K, Karaoulanis S, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges. 2016;14(1):45–49. doi:10.1111/ddg.12729
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Eleftheriadou V, Jones H, et al. Psychosocial effects of vitiligo: a systematic literature review. Am J Clin Dermatol. 2021;22(6):757–774. doi:10.1007/s40257-021-00631-6
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149(2):159–164. doi:10.1001/jamadermatol.2013.927
   PubMed Web of Science ®Google Scholar
• Salman A, Kurt E, Topçuoglu V, et al. Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a cross-sectional controlled study. Am J Clin Dermatol. 2016;17(3):305–311. doi:10.1007/s40257-016-0172-x
   PubMed Web of Science ®Google Scholar
• Sawant NS, Vanjari NA, Khopkar U. Gender differences in depression, coping, stigma, and quality of life in patients of vitiligo. Dermatol Res Pract. 2019;2019:6879412. doi:10.1155/2019/6879412
   PubMed Web of Science ®Google Scholar
• Mishra N, Rastogi MK, Gahalaut P, et al. Dermatology specific quality of life in vitiligo patients and its relation with various variables: a hospital based cross-sectional study. J Clin Diagn Res. 2014;8(6):YC01–YC03. doi:10.7860/JCDR/2014/8248.4508
   PubMedGoogle Scholar
• Dabas G, Vinay K, Parsad D, et al. Psychological disturbances in patients with pigmentary disorders: a cross-sectional study. J Eur Acad Dermatol Venereol. 2019;34(2):392–399. doi:10.1111/jdv.15987
   PubMed Web of Science ®Google Scholar
• Tsadik AG, Teklemedhin MZ, Mehari Atey T, Gidey MT, Desta DM. Public knowledge and attitudes towards vitiligo: a survey in Mekelle City, Northern Ethiopia. Dermatol Res Pract. 2020;2020:3495165. doi:10.1155/2020/3495165
   PubMed Web of Science ®Google Scholar
• Lilly E, Lu PD, Borovicka JH, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69(1):e11–e18. doi:10.1016/j.jaad.2012.01.038
   PubMed Web of Science ®Google Scholar